# Association between the serum uric acid to HDL cholesterol ratio and forearm bone mineral density in middle-aged and older adults

**Authors:** Fangping Song, Yao Sang, Xiuyan Fang, Zilong Tang, Ling Zhang

PMC · DOI: 10.3389/fendo.2026.1710027 · Frontiers in Endocrinology · 2026-02-11

## TL;DR

This study finds that the ratio of serum uric acid to HDL cholesterol is linked to forearm bone density in older adults, with effects varying by age and sex.

## Contribution

The novel contribution is identifying the U-shaped and inverted U-shaped nonlinear associations between UHR and bone density in specific age and sex subgroups.

## Key findings

- Higher UHR is associated with lower forearm BMD in males and overweight individuals.
- A positive association between UHR and BMD is observed in females aged ≥60 years.
- Nonlinear relationships exist in non-overweight individuals and males under 60 years.

## Abstract

Osteoporosis has emerged as a growing public health concern due to its high prevalence and substantial economic burden on both individuals and society. Recent studies have identified the serum uric acid to high-density lipoprotein cholesterol ratio (UHR) as a novel predictive biomarker for various diseases. However, its association with bone mineral density (BMD) remains unclear.

This study evaluated the association of the UHR and forearm BMD (FR-BMD) in a middle-aged and elderly cohort. We also assessed the interaction effects of age, sex, and body mass index (BMI).

A total of 4,958 adults aged ≥50 years were enrolled from health examinees at Heze Municipal Hospital (2022–2025). We collected demographic data, serum lipids, and uric acid levels. Measurements of FR-BMD were performed on the left distal radius (1/3 site) utilizing dual-energy X-ray absorptiometry. Multivariate linear regression analyses evaluated the UHR-BMD relationship, supplemented by subgroup analyses and interaction tests. Nonlinear associations were assessed using generalized additive models with smoothing curves.

After adjusting for age, sex, BMI, Alb, ALP, ALT, BUN, TP, Scr, Lp(a), TC, GGT and hypertension, a higher UHR was significantly associated with lower FR-BMD [β=-0.076, 95%CI(-0.138~-0.015), P = 0.015]. Significant interaction effects were observed for age and sex (P for interaction < 0.05). Subgroup analysis revealed that this inverse association was significant in males and overweight individuals (P < 0.05). In contrast, a positive association was observed in females aged ≥ 60 years [β = 0.278, 95%CI(0.126~0.430), P<0.001]. Nonlinear analyses demonstrated a U-shaped relationship in those with BMI < 24 kg/m² (inflection point: 0. 102), an inverted U-shaped association in females ≥60 years (inflection point: 0. 156) and a significant but nonspecific nonlinear association was observed in males aged <60 years.

The association of UHR with FR-BMD is significantly modified by age and sex in middle-aged and elderly populations. Nonlinear relationships exist in males <60 years, females ≥60 years and non-overweight individuals. The potential of UHR as a novel indicator for bone health assessment in select populations is highlighted by our results.

## Linked entities

- **Diseases:** osteoporosis (MONDO:0005298)

## Full-text entities

- **Genes:** GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}, BTF3P11 (basic transcription factor 3 pseudogene 11) [NCBI Gene 690] {aka BRF3L1, BTF3L1, HUMBTFB, OCIF, OPG, TNFRSF11B}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, GGTLC5P (gamma-glutamyltransferase light chain 5 pseudogene) [NCBI Gene 653590] {aka GGT}, ATHS (atherosclerosis susceptibility (lipoprotein associated)) [NCBI Gene 470] {aka ALP}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, LPA (lipoprotein(a)) [NCBI Gene 4018] {aka AK38, APOA, LP}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}
- **Diseases:** BMD (MESH:D001851), thyroid diseases (MESH:D013959), type 2 diabetes (MESH:D003924), spinal degeneration (MESH:D009410), rheumatoid disorders (MESH:D011695), hepatic or renal diseases (MESH:D007674), Obesity (MESH:D009765), autoimmune diseases (MESH:D001327), Overweight (MESH:D050177), metabolic diseases (MESH:D008659), hyperuricemia (MESH:D033461), metabolic dysregulation (MESH:D021081), cushing syndrome (MESH:D003480), systemic lupus erythematosus (MESH:D008180), chronic inflammation (MESH:D007249), metabolic syndrome (MESH:D024821), fracture (MESH:D050723), hypertension (MESH:D006973), coronary heart disease (MESH:D003327), gout (MESH:D006073), cardiovascular disease (MESH:D002318), endocrine or metabolic disorders (MESH:D004700), malignancy (MESH:D009369), diabetes (MESH:D003920), cerebrovascular disease (MESH:D002561), osteoporotic fractures (MESH:D058866), OP (MESH:D010024)
- **Chemicals:** lipids (MESH:D008055), urea nitrogen (MESH:C530477), cholesterol (MESH:D002784), creatinine (MESH:D003404), Glu (MESH:D005947), ROS (MESH:D017382), calcium (MESH:D002118), SUA (-), 25-hydroxyvitamin D (MESH:C104450), nitrogen (MESH:D009584), uric acid (MESH:D014527), Lp(a) (MESH:D010649), TG (MESH:D014280)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932171/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932171/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932171/full.md

---
Source: https://tomesphere.com/paper/PMC12932171